Új vizsgálatok, publikációk, preprintek és pályázatok ezen a célponton, hónapról hónapra.
Vizsgálat
GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors
2027. okt. 1.· PHASE1 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced Breast Cancer
2027. márc. 1.· PHASE2 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
2027. jan. 1.· PHASE1 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2026. nov. 30.· PHASE2_PHASE3 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
2026. nov. 8.· PHASE2_PHASE3 · NOT_YET_RECRUITING· CTIS
Publikáció
TAVO412, an Anti-EGFR, cMET and VEGF Trispecific Antibody: Initial Results from a Phase I Dose Escalation Study in Patients with Advanced Solid Tumors.
2026. nov. 6.· The oncologist· PUBMED
Publikáció
HB0025, a Novel Anti-PD-L1/VEGF Trap Bispecific Antibody Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer.
2026. nov. 5.· JAMA oncology· PUBMED
Publikáció
A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition.
2026. nov. 4.· Vascular pharmacology· PUBMED
Publikáció
A tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization.
2026. nov. 4.· Proceedings of the National Academy of Sciences of the United States of America· PUBMED
Publikáció
Neu_SPP1 neutrophils are associated with anti-PD-1 resistance in non-small cell lung cancer and implicate VEGF signaling.
2026. nov. 2.· Chinese medical journal· PUBMED
Vizsgálat
South Asian Patients With Diabetic Macular Oedema Treated With Faricimab Assessing the Efficacy, Durability, and Safety (SEAFAR Study)
2026. nov. 1.· PHASE4 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)
2026. nov. 1.· PHASE2_PHASE3 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
The Effects of High-Intensity Interval Training on Gait, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis
2026. nov. 1.· NA · NOT_YET_RECRUITING· CTGOV
Publikáció
Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.
2026. nov. 1.· Drug development research· PUBMED
Publikáció
Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis.
2026. nov. 1.· Journal of biochemical and molecular toxicology· PUBMED
Publikáció
Non-Canonical Function of ORC1: Regulating Notch-VEGFR2-Mediated Angiogenesis in Melanoma Progression.
2026. nov. 1.· Pigment cell & melanoma research· PUBMED
Publikáció
Design, Synthesis, In Vitro Biological Evaluation, and In Silico Studies of Novel Imidazo[4,5-b]Pyridine-Acrylonitrile-Based Derivatives as VEGFR-2 Inhibitors Against Breast Cancer and Hepatocellular Carcinoma.
2026. nov. 1.· Drug development research· PUBMED
Publikáció
PD-(L)1×VEGF bispecific antibodies in solid tumors: clinical trial updates from ASCO 2026.
2026. okt. 31.· Journal of hematology & oncology· PUBMED
Vizsgálat
A First-in-human Trial of SZN-8141 in Diabetic Macular Edema
2026. okt. 30.· PHASE1 · NOT_YET_RECRUITING· CTGOV
Vizsgálat
Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal Cancer
2026. okt. 30.· NA · NOT_YET_RECRUITING· CTGOV
Publikáció
Submacular Hemorrhage Requiring Procedural Intervention During Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Japan: The JTY Three-Center Real-World Incidence Study.
2026. okt. 30.· Retina (Philadelphia, Pa.)· PUBMED
Publikáció
Growth factor VEGF-B sustains intestinal Tfh cell stemness to restrict Taurinivorans outgrowth and microbiota-driven obesity.
2026. okt. 29.· Immunity· PUBMED
Publikáció
Time Course of Resolution of Diabetic Macular Edema by Sustained Suppression of VEGF-A with the Port Delivery Platform with Ranibizumab.
2026. okt. 27.· American journal of ophthalmology· PUBMED
Publikáció
Impact of Anti-VEGF treatment on retinal anatomy and electrophysiological function in diabetic macular edema.
2026. okt. 27.· Documenta ophthalmologica. Advances in ophthalmology· PUBMED
Publikáció
Floralozone alleviates doxorubicin-induced cardiac senescence and fibrosis by inhibiting the VEGFR1.
2026. okt. 27.· Molecular biology reports· PUBMED
Publikáció
Dual VEGF and PD-(L)1 Blockade: Facts and Hopes.
2026. okt. 26.· Clinical cancer research : an official journal of the American Association for Cancer Research· PUBMED
Publikáció
Outcomes of subthreshold diode micropulse laser and anti-VEGF vs anti-VEGF monotherapy for diabetic macular edema: a meta-analysis.
2026. okt. 26.· Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie· PUBMED
Publikáció
Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study.
2026. okt. 25.· Molecular biology reports· PUBMED
Publikáció
VEGFR2-dependent VEGFR3 expression leads to CXCL1/2 and CXCR2 induction in the development of retinal neovascularization.
2026. okt. 25.· Angiogenesis· PUBMED
Publikáció
Ziyin Huatan Recipe Inhibits Lymph Node Metastasis in Gastric Cancer via Downregulating PLAG1-Mediated VEGF-C/VEGFR-3 Signaling.
2026. okt. 24.· Chinese journal of integrative medicine· PUBMED